Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 1,124.00
-11.00 (-0.97%)
Oct 23, 2026, 12:30 PM IST
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 1.12 trillion as of October 22, 2026. It is the 1,841st most valuable company in the world and the 86th biggest in India. Its market cap has increased by 11.48% in one year.
Market Cap
1.12T
Enterprise Value
1.22T
Revenue
285.92B
Global Rank
Country Rank
#86 India
PE Ratio
25.06
ChartMarket Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 1.12T, an increase of 13,580.13%. That is a compound annual growth rate of 22.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 1.12T | 21.86% |
| Dec 31, 2025 | 920.05B | -5.90% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.41T |
| Laurus Labs | 1.12T |
| Cipla | 1.07T |
| Aurobindo Pharma | 932.92B |
| Mankind Pharma | 930.56B |
| Glenmark Pharmaceuticals | 623.72B |
| Alkem Laboratories | 598.30B |
| Gland Pharma | 498.17B |